NCT03729245 · Interventional trial
A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)
Overall registry status Terminated
Phase 3
Conditions Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma
Delaware Valley sites
- Eastern Regional Medical Center - CTCA · Philadelphia, PA · Philadelphia County
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory